A review of the safety and tolerability of aripiprazole
배치운
EXPERT OPINION ON DRUG SAFETY, 200905
172
Pregabalin augmentation to antidepressants in patients with major depressive disorder
배치운
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 200904
173
Desvenlafaxine: A new antidepressant or just another one?
배치운
Expert Opinion on Pharmacotherapy, 200904
174
Comments on Short-Term Testosterone Augmentation in Male Schizophrenics: A Randomized, Double-Blind, Placebo-Controlled Trial by Dr Ko and Colleagues
배치운
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 200904
175
Dysbindin gene (DTNBP1) and schizophrenia in Korean population
serretti a, patkar aa, 전태연, 김정진, de ronchi, mandelli, 배치운
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 200904
176
Effectiveness of antidepressant treatments in pre-menopausal versus post-menopausal women: A pilot study on differential effects of sex hormones on antidepressant effects
Serretti A, De Ronchi D, Steffens DC, Patkar AA, Marks DM, Masand PS, Han C, 김태석, Mandelli L, 배치운
BIOMEDICINE & PHARMACOTHERAPY, 200903
177
The impact of the CONSORT statement on reporting of randomized clinical trials in psychiatry
Patkar AA, Masand PS, Bhatia KS, Wu LT, 배치운, Marks DM, Kwak KP, Han C
CONTEMPORARY CLINICAL TRIALS, 200903
178
Methylphenidate Extended Release (OROS MPH) for the Treatment of Antidepressant-Related Sexual Dysfunction in Patients With Treatment-Resistant Depression: Results From a 4-Week, Double-Blind, Placebo-Controlled Trial
Masand PS, Marks DM, 배치운, Patkar AA, Ciccone P, Mannelli P, Han C, Hooper-Wood C, Peindl K
CLINICAL NEUROPHARMACOLOGY, 200903
179
Augmentation of Dopaminergic Agents for Major Depressive Disorder
Masand PS, Patkar AA, 배치운
JOURNAL OF CLINICAL PSYCHIATRY, 200903
180
Safety and antipsychotic efficacy of forced intramuscular olanzapine over five days: A case report
Conner MJ, Marks DM,, 배치운
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 200902